October 16, 2024
Melanoma
September 24, 2024
Adjuvant Dabrafenib Plus Trametinib for Stage III BRAF V600–Mutated Melanoma: Final Results of the COMBI-AD Trial
The ASCO Post
Daily News
Stay up to date with the latest clinical headlines.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
April 29, 2024
Adjuvant mRNA-Based Personalized Therapy Plus Immunotherapy in High-Risk Resected Melanoma
Conexiant
Advertisement
Recommendations
Advertisement